Conference RAI in low and intermediate risk PTC 2021

QUESTIONS :

• *Does  RRA  have an effect on the long-term outcome of low – risk patient?
• *Does  RRA    (low dose vs high dose) have an effect on the outcome of low- risk patient?
• *Does the use of low dose & high dose iodine affect the recurrence of low- risk patient?
• *Guidelines
• *Conclusions

INTRUDUCTION:

*-Papillary thyroid cancer, the most common endocrine malignancy, offers important public health and individualized treatment challenges to policy makers and clinicians.

*-Although most of these patients do well, the biology of papillary cancer is extremely diverse, ranging from non progressive/extremely indolent lesions to aggressive metastatic cancers.

 McLeod et al Papillary Thyroid Cancer Management Endocrine Reviews,  December 2019, 40(6):1481–149